1
|
Ou Y, You Z, Yao M, Cao Y, Xue X, Chen M, Wu R, Gan L, Li D, Wu P, Xu X, Wong W, Wong VKW, Liu W, Ye J, Jin J. Naproxen-Derived New Compound Inhibits the NF-κB, MAPK and PI3K/Akt Signaling Pathways Synergistically with Resveratrol in RAW264.7 Cells. Molecules 2023; 28:molecules28083395. [PMID: 37110629 PMCID: PMC10146875 DOI: 10.3390/molecules28083395] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2023] [Revised: 03/23/2023] [Accepted: 04/04/2023] [Indexed: 04/29/2023] Open
Abstract
Naproxen is widely used for anti-inflammatory treatment but it can lead to serious side effects. To improve the anti-inflammatory activity and safety, a novel naproxen derivative containing cinnamic acid (NDC) was synthesized and used in combination with resveratrol. The results showed that the combination of NDC and resveratrol at different ratios have a synergistic anti-inflammatory efficacy in RAW264.7 macrophage cells. It was indicated that the combination of NDC and resveratrol at a ratio of 2:1 significantly inhibited the expression of carbon monoxide (NO), tumor necrosis factor α (TNF-α), interleukin 6 (IL-6), induced nitric oxide synthase (iNOS), cyclooxygenase 2 (COX-2) and reactive oxygen species (ROS) without detectable side effects on cell viability. Further studies revealed that these anti-inflammatory effects were mediated by the activation of nuclear factor kappa-B (NF-κB), mitogen-activated protein kinase (MAPK) and phosphoinositide-3 kinase (PI3K)/protein kinase B (Akt) signaling pathways, respectively. Taken together, these results highlighted the synergistic NDC and resveratrol anti-inflammatory activity that could be further explored as a strategy for the treatment of inflammatory disease with an improved safety profile.
Collapse
Affiliation(s)
- Yi Ou
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
| | - Zonglin You
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
| | - Min Yao
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
| | - Yingfan Cao
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
| | - Xiu Xue
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
| | - Min Chen
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
| | - Rihui Wu
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Lishe Gan
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Dongli Li
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Panpan Wu
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Xuetao Xu
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Wingleung Wong
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Vincent Kam Wai Wong
- Neher's Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau 999078, China
| | - Wenfeng Liu
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| | - Jiming Ye
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- Lipid Biology and Metabolic Disease Research Group, School of Health and Biomedical Sciences, RMIT University, Melbourne, VIC 3000, Australia
| | - Jingwei Jin
- School of Biotechnology and Health Sciences, Wuyi University, Jiangmen 529020, China
- International Healthcare Innovation Institute (Jiangmen), Jiangmen 529040, China
| |
Collapse
|
2
|
Zheng Y, Pan C, Zhang Z, Luo W, Liang X, Shi Y, Liang L, Zheng X, Zhang L, Du Z. Antiaging effect of Curcuma longa L. essential oil on ultraviolet-irradiated skin. Microchem J 2020. [DOI: 10.1016/j.microc.2020.104608] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
3
|
Zhou W, Liu Q, Zang X, Hu M, Yue Y, Wang Y, Lv C, Du Z. Combination use of tolfenamic acid with curcumin improves anti-inflammatory activity and reduces toxicity in mice. J Food Biochem 2020; 44:e13240. [PMID: 32281661 DOI: 10.1111/jfbc.13240] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2020] [Revised: 03/18/2020] [Accepted: 03/24/2020] [Indexed: 12/13/2022]
Abstract
Long-term use of tolfenamic acid inevitably causes side effects, including gastric ulcer and hepatotoxicity. Curcumin is generally recognized to be anti-inflammatory, hepatoprotective, and gastroprotective. Herein, we investigated the combinational effects of tolfenamic acid and curcumin and possible mechanism in a TPA-induced inflammation mouse model. Combinational use of tolfenamic acid (100 mg/kg) and curcumin (100 mg/kg) by oral administration reduced dermal inflammation represented by ear edema and lymphocytic infiltration. Moreover, curcumin dispersed in polyvinyl pyrrolidone showed stronger synergistic effect. The beneficial effect of the coadministration was also reproduced in PKC/Akt/IKK/NF-κB signaling pathways. Notably, hepatoprotective and gastroprotective effect was exhibited by the reverse of body weight loss and NF-κB downregulation in the liver, and by increased Spleen Index of mice. These results suggested combination administration of tolfenamic acid with curcumin enhances anti-inflammatory efficacy and reduces hepatic/gastric toxicity, which indicates dietary uptake of curcumin may facilitate the function of tolfenamic acid. PRACTICAL APPLICATIONS: Curcumin, a representative polyphenolic compound, is one of the main constituents of dietary spice turmeric which has been widely consumed throughout the world, especially in Asia. The beneficial aspect of combination use of curcumin in enhancing anti-inflammatory effect and reducing hepatic/gastric toxicity of NSAID drug tolfenamic acid in mice has been explored. It might be anticipated as a potential naturally derived bioactive constituent in functional food and pharmaceutical applications.
Collapse
Affiliation(s)
- Wei Zhou
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Higher Education Mega Centre, Guangzhou, PR China
| | - Qifa Liu
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Higher Education Mega Centre, Guangzhou, PR China
| | - Xiaohao Zang
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Higher Education Mega Centre, Guangzhou, PR China
| | - Mengmeng Hu
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Higher Education Mega Centre, Guangzhou, PR China
| | - Yuan Yue
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Higher Education Mega Centre, Guangzhou, PR China
| | - Yuchu Wang
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Higher Education Mega Centre, Guangzhou, PR China
| | - Chunyan Lv
- Department of Materials Chemistry, Huzhou University, Huzhou, PR China
| | - Zhiyun Du
- School of Biomedical and Pharmaceutical Sciences, Guangdong University of Technology, Higher Education Mega Centre, Guangzhou, PR China
| |
Collapse
|
4
|
Liu W, Huang S, Li Y, Zheng X, Zhang K. Synergistic effect of tolfenamic acid and glycyrrhizic acid on TPA-induced skin inflammation in mice. MEDCHEMCOMM 2019; 10:1819-1827. [PMID: 31814955 PMCID: PMC6839815 DOI: 10.1039/c9md00345b] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/03/2019] [Accepted: 07/16/2019] [Indexed: 01/14/2023]
Abstract
Tolfenamic acid (TA) and glycyrrhizic acid (GA) are well-known components with anti-inflammatory properties. However, their combined effects on inflammation have not been well studied. The present study aimed to investigate the in vivo anti-inflammatory effects of TA combined with GA using a 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced mouse ear edema model, as well as the underlying mechanisms thereof. The results indicated that TA combined with GA led to a stronger inhibition on TPA-induced mouse ear edema compared to the singular treatments. In addition, the combined treatment significantly alleviated subcutaneous tissue inflammation caused by TPA. Further mechanistic investigations demonstrated that TA combined with GA decreased the levels of TPA-induced interleukin-1β (IL-1β), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α). Furthermore, the combined treatment effectively inhibited nuclear factor-κB (NF-κB), extracellular signal-regulated kinase (ERK1/2), c-Jun N-terminal kinase (JNK), phosphor-ERK1/2 and phosphor-JNK, which was accompanied by blocking of the activation and the phosphorylation in mitogen-activated protein kinase (MAPK) and phosphoinositide 3-kinase (PI3K)/Akt signaling pathways. Collectively, our findings revealed that different anti-inflammatory components used in combination lead to enhanced inhibitory effects against inflammation.
Collapse
Affiliation(s)
- Wenfeng Liu
- School of Biotechnology and Health Sciences , Wuyi University , Jiangmen 529020 , China
- International Healthcare Innovation Institute (Jiangmen) , China
| | - Shun Huang
- Nanfang PET Center , Nanfang Hospital , Southern Medical University , Guangzhou , Guangdong 510515 , China .
| | - Yonglian Li
- Guangdong Industry Polytechnic , Guangzhou , 510300 , China
| | - Xi Zheng
- School of Biotechnology and Health Sciences , Wuyi University , Jiangmen 529020 , China
- Susan Lehman Cullman Laboratory for Cancer Research , Department of Chemical Biology , Ernest Mario School of Pharmacy, Rutgers , The State University of New Jersey , Piscataway , NJ 08854 , USA
| | - Kun Zhang
- School of Biotechnology and Health Sciences , Wuyi University , Jiangmen 529020 , China
| |
Collapse
|
5
|
Rakariyatham K, Du Z, Yuan B, Gao Z, Song M, Pan C, Han Y, Wu X, Tang Z, Zhang G, Xiao H. Inhibitory effects of 7,7′-bromo-curcumin on 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation. Eur J Pharmacol 2019; 858:172479. [DOI: 10.1016/j.ejphar.2019.172479] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/02/2019] [Revised: 06/17/2019] [Accepted: 06/18/2019] [Indexed: 12/30/2022]
|
6
|
Zhang L, Yang Z, Huang Z, Zhao M, Li P, Zhou W, Zhang K, Zheng X, Lin L, Tang J, Fang Y, Du Z. Variation in Essential Oil and Bioactive Compounds of Curcuma kwangsiensis Collected from Natural Habitats. Chem Biodivers 2017; 14. [PMID: 28398606 DOI: 10.1002/cbdv.201700020] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/19/2017] [Accepted: 04/07/2017] [Indexed: 11/08/2022]
Abstract
The chemical compositions of essential oils (EOs) extracted from Curcuma kwangsiensis rhizomes collected from six natural habitats in P. R. China were evaluated using gas chromatography/mass spectrometry (GC/MS). Fifty-seven components were identified from the six EOs, and their main constituents were 8,9-dehydro-9-formyl-cycloisolongifolene (2.37 - 42.59%), germacrone (6.53 - 22.20%), and l-camphor (0.19 - 6.12%). The six EOs exhibited different DPPH radical-scavenging activities (IC50 , 2.24 - 31.03 μg/ml), with the activity of most of EOs being much higher than that of Trolox C (IC50 , 10.49 μg/ml) and BHT (IC50 , 54.13 μg/ml). Most EOs had potent antimicrobial effects against the tested bacteria and fungus. They also exhibited cytotoxicity against B16 (IC50 , 4.44 - 147.4 μg/ml) and LNCaP cells (IC50 , 73.94 - 429.25 μg/ml). The EOs showed excellent anti-inflammatory action by significantly downregulating expression of pro-inflammatory cytokines, cyclooxygenase-2, and tumor necrosis factor-α. This study provides insight into the interrelation among growth location, phytoconstituents, and bioactivities, and the results indicate the potential of C. kwangsiensis as natural nutrients, medicines, and others additives.
Collapse
Affiliation(s)
- Lanyue Zhang
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| | - Zhiwen Yang
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| | - Zebin Huang
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| | - Mincong Zhao
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| | - Penghui Li
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| | - Wei Zhou
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| | - Kun Zhang
- School of Chemical and Environment Engineering, Wuyi University, Jiangmen, 529020, P. R. China
| | - Xi Zheng
- Susan Lehman Cullman Laboratory for Cancer Research, Department of Chemical Biology, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, 164 Frelinghuysen Road, Piscataway, NJ, 08854, USA
| | - Li Lin
- Allan Conney Biotechnology Company Ltd, Foshan, 528200, P. R. China
| | - Jian Tang
- Infinitus (China) Company Ltd, Guangzhou, 510006, P. R. China
| | - Yanxiong Fang
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| | - Zhiyun Du
- Institute of Natural Medicine & Green Chemistry, School of Chemical Engineering and Light Industry, Guangdong University of Technology, Guangzhou, Guangdong, 510006, P. R. China
| |
Collapse
|